Provenienza dei contatti di primo grado di Pascal Prudent
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Recipharm Fontaine SAS
Recipharm Fontaine SAS Pharmaceuticals: MajorHealth Technology Part of Recipharm AB, Recipharm Fontaine SAS is a French pharmaceutical company that manufactures pharmaceutical products. The company is based in Fontaine-les-Dijon, France. The company was founded in 2008. Pascal Prudent has been the CEO of the company since 2017.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Pascal Prudent tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
CONSORT MEDICAL PLC | Pharmaceuticals: Major | Director/Board Member | |
Provell Pharmaceuticals LLC
Provell Pharmaceuticals LLC Medical DistributorsDistribution Services Provell Pharmaceuticals LLC is a healthcare company, which engages in marketing and distribution of pharmaceutical products. It offers products of Merck KGaA including Euthyrox. The company was founded by Jim Small and Kurt Kalm in 2005 and is headquartered in Honey Brook, PA. | Medical Distributors | Director/Board Member | |
ICI Chemicals & Polymers Ltd.
ICI Chemicals & Polymers Ltd. Chemicals: Major DiversifiedProcess Industries ICI Chemicals & Polymers Ltd. manufactures chemicals and paints. The firm's products include petrochemicals, fertilizers, plastics, polymers, surfactants and industrial chemicals. It also manufactures CPs carried out by ICI Chemicals & Polymers Group. The company is headquartered in Middlesbrough, UK. | Chemicals: Major Diversified | Corporate Officer/Principal | |
Nottingham Trent University | College/University | Undergraduate Degree | |
RECIPHARM AB (PUBL) | Biotechnology | Founder Corporate Officer/Principal | |
The Open University | College/University | Masters Business Admin | |
Celltech Manufacturing Services Ltd.
Celltech Manufacturing Services Ltd. Pharmaceuticals: MajorHealth Technology Part of Inyx, Inc., Celltech Manufacturing Services Ltd. is a British pharmaceutical manufacturing company. The company is based in Ashton-under-Lyne, UK. Celltech Manufacturing Services was acquired by Inyx, Inc. from UCB SA on August 31, 2005 for $33.70 million. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Recipharm Monts SAS
Recipharm Monts SAS Pharmaceuticals: MajorHealth Technology Part of Recipharm AB, Recipharm Monts SAS is a company that manufactures sterile injectable anesthetic products. The company is based in Monts, France. Carl Ericson has been the CEO of the French company since 2019. | Pharmaceuticals: Major | Chairman Director/Board Member | |
KAHR Medical Ltd.
KAHR Medical Ltd. Pharmaceuticals: MajorHealth Technology KAHR Medical Ltd. develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases. Its drug pipeline is built around the signal converter proteins a unique class of multi-functional therapeutic agents that convert signals sent from one cell to another. The firm?s therapeutic proteins integrate two functional units, enabling each one to elicit multiple cooperative functional endpoints. The company was founded by Mark L. Tykocinski in 2005 and is headquartered in Jerusalem, Israel. | Pharmaceuticals: Major | Director/Board Member | |
SymCel AB
SymCel AB Medical SpecialtiesHealth Technology SymCel AB develops and markets analytical instrumentations for cell biological research and development. Its products include calScreener, calPlate System, and calView date collection and analysis software. The company was founded by Dan Rolf Stefan Hallen and Bertil Ingemar Wadso in 2004 and is headquartered in Spanga, Sweden. | Medical Specialties | Director/Board Member | |
Aesica Formulation Development Ltd.
Aesica Formulation Development Ltd. Pharmaceuticals: MajorHealth Technology Aesica Formulation Development Ltd. develops pharmaceutical products. It offers sterile and nutraceutical product development and drug delivery services. The company was founded on December 22, 2005 and is headquartered in Northumberland, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
SwedenBIO Service AB
SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services SwedenBIO Service AB is a non-profit company that develops biotechnology, diagnostics, pharmaceuticals, and medical technology. It also offers counseling, education, opinion formation, and investigations. The company was founded in 2002 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Director/Board Member | |
Cobra Biologics Ltd.
Cobra Biologics Ltd. Pharmaceuticals: MajorHealth Technology Cobra Biologics Ltd. engages in development of DNA-based technologies, services and products. It is a international contract development and manufacturing organization (CDMO) providing biologics and pharmaceuticals for pre-clinical, clinical and commercial supply. The company was founded in 1992 and is headquartered in Keele, the United Kingdom. | Pharmaceuticals: Major | Chairman | |
Recipharm Ltd.
Recipharm Ltd. Pharmaceuticals: MajorHealth Technology Recipharm Ltd. manufactures pharmaceutical products. It offers branded and generic products. The company was founded on August 10, 2012 and is headquartered in Ashton-under-Lyne, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Wasserburger Arzneimittelwerk GmbH
Wasserburger Arzneimittelwerk GmbH Pharmaceuticals: MajorHealth Technology Part of Recipharm AB, Wasserburger Arzneimittelwerk GmbH is a German company that manufactures injectable pharmaceuticals. The company is based in Wasserburg am Inn, Germany. The company was founded in 1989. The CEO is Michael Isele. Wasserburger Arzneimittelwerk was acquired by Recipharm AB from Hospira, Inc. on January 31, 2010. | Pharmaceuticals: Major | Director/Board Member | |
Recip AB
Recip AB Pharmaceuticals: MajorHealth Technology Part of Viatris, Inc., Recip AB is a company that manufactures pharmaceutical products. Recip AB is based in Arsta, Sweden. Recip was acquired by Meda AB, part of Viatris, Inc. from August 24, 2016 on December 31, 2007 for $475.65 million. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Recipharm Parets SL
Recipharm Parets SL Pharmaceuticals: MajorHealth Technology Part of Recipharm AB, Recipharm Parets SL is a Spanish pharmaceutical company that manufactures pharmaceutical products. The company is based in Barcelona, Spain. | Pharmaceuticals: Major | Director/Board Member | |
Zentricity International AB
Zentricity International AB Financial ConglomeratesFinance Zentricity International AB provides investment services. The private company is based in Stockholm, Sweden. | Financial Conglomerates | Director/Board Member | |
Cobra Biologics Holding AB
Cobra Biologics Holding AB Pharmaceuticals: MajorHealth Technology Cobra Biologics Holding AB manufactures biologics and pharmaceuticals for pre-clinical, clinical, and commercial products. Its services include gene therapies and vaccines, products for testing, process development and scale up of vaccine products, production of sterile drug products, and process development and production, automation, and traceability of programs. The company was founded in 2011 and is headquartered in S?dert?lje, Sweden. | Pharmaceuticals: Major | Chairman | |
Aesica Holdco Ltd.
Aesica Holdco Ltd. Pharmaceuticals: MajorHealth Technology Part of Recipharm AB, Aesica Holdco Ltd. operates as a holding British company. The company is based in Hemel Hempstead, UK. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
XINTELA AB | Biotechnology | Director/Board Member | |
Cormorant Pharmaceuticals AB
Cormorant Pharmaceuticals AB BiotechnologyHealth Technology Cormorant Pharmaceuticals AB provides biopharmaceutical products.The company was founded by Maarten de Chateau and Urban Paulsson in 2010 and is headquartered in Solna, Sweden. | Biotechnology | Director/Board Member | |
B&E Invest AB | Director/Board Member | ||
TOLERANZIA AB | Biotechnology | Director/Board Member | |
Chromafora AB
Chromafora AB Environmental ServicesIndustrial Services Chromafora AB offers water purification and technology for selective heavy metal separation to a global market. It provides chemical reducing technology. Its services include selective metal extraction to handle waste streams containing dissolved heavy metals and chemical synthesis. The company was founded by Martin Kullberg, Karl Gaston Lavén, and Henrik Joachim Rundgren in 2010 and is headquartered in Solna, Sweden. | Environmental Services | Director/Board Member | |
Linköping Institute of Technology | College/University | Graduate Degree | |
Empros Pharma AB
Empros Pharma AB Pharmaceuticals: MajorHealth Technology Empros Pharma AB is a pharmaceutical company based in Sweden that focuses on developing drugs to combat obesity. The CEO is Arvid Söderhäll, and the company is located in Solna, Sweden. The Swedish company has developed a weight-loss combination product containing orlistat and acarbose, which has been tested in a randomized, placebo-controlled trial. Empros Pharma's main drug, EMP16, is designed to delay food digestion and absorption processes in the small intestine using a proprietary advanced drug delivery technology. The company was founded in 2013 by senior researchers and entrepreneurs at Uppsala University, along with external investor Flerie Invest. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Flerie Invest AB
Flerie Invest AB Investment ManagersFinance Flerie Invest AB (Flerie Invest) is a venture capital subsidiary of Flerie Creations Ltd. founded in 2011. The firm is headquartered in Stockholm, Sweden. | Investment Managers | Chairman Private Equity Investor | |
UCB Pharma Ltd.
UCB Pharma Ltd. Pharmaceuticals: MajorHealth Technology UCB Pharma Ltd. operates as a biopharmaceutical company. The firm focuses on developing medicines for severe diseases in Immunology and CNS. The company is headquartered in Slough, the United Kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Bohus HoldCo AB
Bohus HoldCo AB Chemicals: Major DiversifiedProcess Industries Bohus BioTech AB is a Swedish company that manufactures and develops hyaluronic acid products. The company is based in Stromstad, Sweden and has subsidiaries in Sweden. The company was founded in 1992 by Daniel C. Ogbonnaya. | Chemicals: Major Diversified | Director/Board Member | |
Trimeta LLC | Chairman | ||
B&E Participation, Inc. | Chairman | ||
Pingvinen Penningplacering AB | Director/Board Member | ||
Zentricity Holding AB
Zentricity Holding AB Financial ConglomeratesFinance Zentricity Holding AB provides investment services. It offers venture capital to startup companies. The company is headquartered in Stockholm, Sweden. | Financial Conglomerates | Director/Board Member | |
Sixera Pharma AB
Sixera Pharma AB Pharmaceuticals: GenericHealth Technology Sixera Pharma AB conducts activities within research, development, and commercialization of pharmaceuticals. It develops treatment for Netherton syndrome. The company was founded by Jean Nordstrom on August 21, 2012 and is headquartered in Göteborg, Sweden. | Pharmaceuticals: Generic | Director/Board Member | |
Flerie Participation AB
Flerie Participation AB Financial ConglomeratesFinance Flerie Participation AB is an investment holding Swedish company. The company is based in Stockholm, Sweden. | Financial Conglomerates | Director/Board Member | |
Prokarium Ltd.
Prokarium Ltd. Miscellaneous Commercial ServicesCommercial Services Prokarium Ltd. operates as a biopharmaceutical company that focuses on developing vaccination solutions based on synthetic biology. Its oral vaccine delivery platform Vaxonella stimulates broad protective immune responses applicable to a wide range of diseases. The company is headquartered in Keele, the United Kingdom. | Miscellaneous Commercial Services | Chairman | |
Amarna Therapeutics BV
Amarna Therapeutics BV Medical/Nursing ServicesHealth Services Amarna Therapeutics BV operates as a biotechnology company developing SVac viral gene delivery vector platform. The firm has developed a proprietary SuperVero cell line and SVec gene delivery platform for the development of safe and efficient immunotherapies for major indications within the degenerative, inflammatory and autoimmune disease areas. The company was founded by Ben van Leent and Peter de Haan in 2008 and is headquartered in Leiden, the Netherlands. | Medical/Nursing Services | Chairman | |
Binx Health Ltd.
Binx Health Ltd. Miscellaneous Commercial ServicesCommercial Services Part of binx health, inc., Binx Health Ltd. is a British company that engages in research and development on biotechnology. The company is based in Trowbridge, UK. The company was founded in 2005. The CEO is Jeffrey R. Luber. | Miscellaneous Commercial Services | Director/Board Member | |
Recipharm Verwaltungs GmbH
Recipharm Verwaltungs GmbH Financial ConglomeratesFinance Part of Recipharm AB, Recipharm Verwaltungs GmbH is an investment holding German company. The company is based in Wasserburg am Inn, Germany. The CEOs of the company are Michael Isele, Thomas Bengt Eldered. | Financial Conglomerates | Chief Executive Officer | |
Prokarium Holdings Ltd.
Prokarium Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services Prokarium Holdings Ltd. provides management services. The private company is based in London, UK. The British company was founded in 2014. Kristen Albright has been the CEO of the company since 2018. | Miscellaneous Commercial Services | Chairman | |
Recipharm Holdings Ltd.
Recipharm Holdings Ltd. MiscellaneousMiscellaneous Recipharm Holdings Ltd. operates from a multipurpose manufacturing facility, The company was founded on August 10, 2012 and is headquartered in Ashton-Under-Lyne, the United Kingdom. | Miscellaneous | Director/Board Member Director/Board Member | |
Consort Medical GmbH
Consort Medical GmbH Financial ConglomeratesFinance Part of Recipharm AB, Consort Medical GmbH is a German company that functions as an investment holding company. The company is based in Monheim, Germany. The CEO of the company is Thomas Bengt Eldered. | Financial Conglomerates | Chief Executive Officer | |
Buzzard Pharmaceuticals AB
Buzzard Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Buzzard Pharmaceuticals AB develops oncology drugs. The company is based in Stockholm, Sweden. The Swedish company was founded by Urban Paulsson. The CEO is Maarten de Château. | Pharmaceuticals: Major | Director/Board Member | |
Recipharm HC Ltd.
Recipharm HC Ltd. Pharmaceuticals: MajorHealth Technology Founded in 2018, Recipharm HC Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. Part of Recipharm AB, the company is based in Cheshire, UK. | Pharmaceuticals: Major | Director/Board Member | |
NorthX Biologics Matfors AB
NorthX Biologics Matfors AB BiotechnologyHealth Technology NorthX Biologics Matfors AB is a biologics company that specializes in high-quality protein production and DNA manufacturing. The company is based in Matfors, Sweden, and has subsidiaries in Sweden. The Swedish company offers comprehensive cell banking services, including master cell bank production, GMP cell banking, and cell bank characterization, ensuring quality and compliance for biological products. The company also provides premium plasmid DNA services, offering GMP, High Quality, and Research Grade plasmids for gene therapy, cell therapy, molecular biology research, and clinical applications. The company was founded in 1963, and Janet Hoogstraate has been the CEO of the company since 2023. | Biotechnology | Chairman | |
NANOLOGICA AB | Pharmaceuticals: Major | Director/Board Member |
Statistiche
Distribuzione geografica
Svezia | 26 |
Regno Unito | 16 |
Stati Uniti | 4 |
Germania | 4 |
Francia | 2 |
Settori
Health Technology | 27 |
Finance | 8 |
Commercial Services | 5 |
Consumer Services | 4 |
Process Industries | 3 |
Posizioni
Director/Board Member | 35 |
Chairman | 12 |
Corporate Officer/Principal | 8 |
Chief Executive Officer | 3 |
President | 2 |
Contatti più connessi
Insiders | |
---|---|
Thomas Bengt Eldered | 41 |
Mark Royston Quick | 19 |
- Borsa valori
- Insiders
- Pascal Prudent
- Connessioni Società